Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2026-05-04 @ 10:46 PM
Study NCT ID:
NCT05546957
Status:
COMPLETED
Last Update Posted:
2023-05-24
First Post:
2022-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assess Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban in Healthy Adult Participants
Sponsor:
Regeneron Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy Volunteer | View |